FAIRFIELD, Conn., Oct. 22, 2009 (GLOBE NEWSWIRE) -- Competitive Technologies, Inc. (NYSE Amex:CTT) announced today that the University of Wisconsin-Madison will use CTT’s pain therapy medical device to treat patients at its Carbone Cancer Center in the School of Medicine and Public Health, under the direction of Toby C. Campbell, M.D., Miroslav “Misha” Backonja, M.D., and James Cleary, M.D. Drs. Cleary and Campbell are national leaders in palliative care at the University of Wisconsin Carbone Cancer Center. Dr. Backonja is recognized as a global authority in neuropathic pain treatment and is Professor of Neurology at the University of Wisconsin School of Medicine and Public Health. Dr. Cleary is Director Palliative Care at the University of Wisconsin School of Medicine and Public Health. Dr. Campbell’s clinical research interests are in lung cancer therapeutics, chemotherapy-induced peripheral neuropathy, symptom management, and interdisciplinary medical teams.
